Procalcitonin in patients with acute and chronic renal insufficiency

Wiener Klinische Wochenschrift

Volumn 116, Issue 24, 2004, Pages 849-853

  Steinbach, Gerald ^a   Bölke, Edwin ^b   Grünert, Adolf ^a   Orth, Klaus ^c,e   Störck, Martin ^d  

^a UNIVERSITY OF ULM   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c Department of Surgery   (Germany)

^d STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

^e Medizinische Klinik II   (Germany)

Author keywords

C reactive protein; Hemodialysis; Inflammation; Peritoneal dialysis; Procalcitonin; Renal failure

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CHRONIC KIDNEY FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PROTEIN BLOOD LEVEL; RELIABILITY; SENSITIVITY AND SPECIFICITY; SEPSIS;

ADULT; AGED; AGED, 80 AND OVER; BACTERIAL INFECTIONS; C-REACTIVE PROTEIN; CALCITONIN; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMOFILTRATION; HUMANS; INFLAMMATION; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PROTEIN PRECURSORS; RENAL DIALYSIS; SENSITIVITY AND SPECIFICITY; SEPSIS; TIME FACTORS;

EID: 12344337482     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-004-0279-6     Document Type: Article

References (35)

1. Al-Nawas B, Kramer I, Sha PM (1996) Procalcitonin in the diagnosis of severe infections. Eur J Med Res 1: 331-333
2. Le Moullec JM, Jullienne A, Chenais J, Lasmoles F, Guliana JM, Milhaud G, Moukhtar MS (1984) The complete sequence of human preprocalcitonin. FEBS Letter 167: 93-97
3. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341: 515-518
4. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C (1994) Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 79: 1605-1608
5. Nishikura T (1999) The clearance of procalcitonin (PCT) during continuous veno-venous haemodiafiltration (CV-VHD) [Letter]. Intens Care Med 25: 1198-1199
6. Willging S, Keller F, Steinbach G (1998) Specificity of cardiac troponins I and T in renal disease. Clin Chem Lab Med 36: 87-92
7. Nijsten MW et al (2000) Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 28: 458-461
8. Remskar M, Horvat M, Hojker S, Noc M (2002) Procalcitonin in patients with acute myocardial infarction. Wien Klin Wochenschr 114: 205-210
9. Pusch F, Wildling E, Freitag H, Weinstabl C (2001) Procalcitonin as a diagnostic marker in patients with aspiration after closed head injury. Wien Klin Wochenschr 113: 676-680
10. Mallioux LU, Belluci AG, Wilkes BM, Napolitano B, Mossey RT, Lesser M, Bluestone PA (1991) Mortality in dialysis patients. Analysis of the causes of death. Am J Kidney Dis 18: 326-335
11. Owen WF, Lowrie EG (1998) C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 54: 627-636
12. Iseki K, Tozawa M, Yoshi S, Fukiyama K (1999) Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant 14: 1956-1960
13. Level C, Chauveau P, Delmas Y, Lasseur C, Pelle G, Peuchant E, Montaudon D, Combe C (2001) Procalcitonin - a new marker of inflammation in haemodialysis patients? Nephrol Dial Transplant 16: 980-986
14. Herget-Rosenthal S, Marggraf G, Pietruck F, Hüsing J, Strupat M, Philipp T, Kribben A (2001) Procalcitonin for accurate detection of infection in haemodialysis. Nephrol Dial Transplant 16: 975-979
15. Eberhard OK, Haubitz M, Brunkhorst FM, Kliem V, Koch KM, Brunkhorst R (1997) Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 40: 1250-1256
16. Tan EM, Cohen AS, Fries JF, Masi AT, Mc Shane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-1277
17. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CGM, McCluskey RT, Sinico RA, Rees AJ, van Es LA, Waldherr R, Wiik A (1994) Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 37: 187-192
18. Utgarte H, Silva E, Mercan D, De Mendonca A, Vincent JL (1999) Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 27: 498-504
19. De Werra I, Jaccard C, Corradin SB, Chiolero R, Yersin B, Gallati H, Assicot M, Bohuon C, Baumgartner J-D, Glauser MP, Heumann D (1997) Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock and bacterial pneumonia. Crit Care Med 25: 607-613
20. Oberhoffer M, Stonans I, Russwurm S, Stonane E, Vogelsang H, Junker U, Jäger L, Reinhart K (1999) Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 134: 49-55
21. Herbelin A, Nguyen AT, Zingraff J, Deschamps-Latscha B (1990) Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor α. Kidney Int 37: 116-125
22. Nijsten MWN, Olinga P, The TH, de Vries EG, Koops HS, Groothuis GM, Limburg PC, ten Duis HJ, Moshage H, Hoekstra HJ, Bijzet J, Zwaveling JH (2000) Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 28: 458-461
23. Brunkorst FM, Heinz U, Forycki ZF (1998) Kinetics of procalcitonin in iatrogenic sepsis. Intens Care Med 24: 888-889
24. Eberhard OK, Langefeld I, Kuse ER, Brunkhorst FM, Kliem V, Schlitt HJ, Pichlmayr R, Koch KM, Brunkhorst R (1998) Procalcitonin in the early phase after renal transplantation - will it add to diagnostic accuracy? Clin Transplant 12: 206-211
25. Nylen ES, Whang KT, Snider RH, Steinwald PM, White JC, Becker KL (1998) Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 26: 1001-1006
26. Mimoz O, Benoist JF, Edouard AR, Assicot M, Bohoun C, Samii K (1998) Procalcitonin and C-reactive protein during the early postraumatic systemic inflammatory response syndrome. Intens Care Med 24: 187-188
27. Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schüttler J (1998) Postoperative plasma concentrations of procalcitonin after different types of surgery. Intens Care Med 24: 680-684
28. Kilger E, Pichler B, Goetz AE, Rank N, Welte M, Mörstedt K, Vetter HO, Gödje O, Schmitz C, Lamm P, Engelschalk E, Muehlbeyer D, Frey L (1998) Procalcitonin as a marker of systemic inflammation after conventional or minimally invasive coronary artery bypass grafting. Thorac Cardiovasc Surg 46: 130-133
29. Schmidt M, Burchardi C, Sitter T, Held E, Schiffl H (2000) Procalcitonin in patients undergoing chronic hemodialysis. J Nephrol 84: 187-188
30. Rau B, Steinbach G, Gansauge F, Mayer JM, Grünert A, Beger HG (1997) The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 41: 832-840
31. Lotric-Furlan S, Maraspin-Carman V, Cimperman J, Ogrinc K, Stopar T, Strle F (2002) Procalcitonin levels in patients with Lyme borreliosis. Wien Klin Wochenschr 114: 530-532
32. European Renal Association European-Dialysis and Transplant Association (ERA-EDTA) Report on Management of Renal Failure in Europe (1995) Causes of death. Nephrol Dial Transplant 10 [Suppl 5]: 11-12
33. Bailey JL, Mitch WE (2000) Haemodialysis. In: Brenner BM (ed) The kidney. Saunders, Philadelphia, pp 2373-2453
34. Dahaba A, Rehak P, List W (2003) Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing haemodialysis. Intensive Care Med 29: 579-583
35. Sitter T, Schmidt M, Schneider S, Schiffl H (2002) Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin. J Nephrol 15: 297-301